Replies to post #14291 on US Stem Cell Inc (USRM)

[Nano1]

Especially with the latest news, we should be much higher.
The company has proven that they are trying to be successful!
Facts are Facts!

Read it again!

SUNRISE, FL / ACCESSWIRE / March 17, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB:BHRT), an emerging enterprise in the regenerative medicine / cellular therapy industry is pleased to announce, following the release of its Form 10-K Annual Report, key 2014 accomplishments including but not limited to:

1. A 2,040% increase in year over year revenues to $2.1 million in 2014 from $0.1 million in 2013.

2. A 28% decrease in year over year net loss to ($2.25) million in 2014 from ($3.14) million in 2013.

3. A 42% decrease in year over year cash used in operating activities to $1.1 million in 2014 from $1.9 million in 2013.

4. A 20% reduction ($2.3 million) in year over year current liabilities to $11.1 million at December 31, 2014 from $13.4 million at December 31, 2013.

5. A 20% reduction in the Company's working capital deficit.

[Gsdubb]

You're right .2 is too low. More like $1 right now.
Cardio3 has a $200-300 million Market cap.
Bioheart is ahead of the game and other products now in the pipeline...

[Tfan15]

"OK? So this is a "fake" free market share price and not the "real" imaginary, make up a wish price of .20 "minimum"?? "
"How does that work exactly? A FREE MARKET where shares are bought and sold based on supply and demand is FAIRLY PRICING a stock right now at about .009, aka 9/10ths of ONE CENT. Buyers and sellers are trading actively in real time paying .009 or so, but that's the "fake" price and it should really be like 20X more at .20 "minimum"?? Wow !! "


I plan to reference these comments when the stock price hits $1.